ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
39.68
0.69%
US Tech 100
20,422.00
-0.13%
S&P 500
5,868.55
-0.22%
US Dollar vs CAD
1.44028
0.19%
Bitcoin
96,770.00
2.52%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE
  6. Syntheticmr Ab (publ) (0G79)

  7. Syntheticmr Ab (publ) (0G79) News

0G79

Syntheticmr Ab (publ) (0G79)

Syntheticmr Ab (publ)
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:0G79
DateTimeSourceHeadlineSymbolCompany
12/06/20242:12PMPR Newswire (US)SyntheticMR receives FDA 510(k) clearance for SyMRI 15LSE:0G79Syntheticmr Ab (publ)
10/02/20243:23AMPR Newswire (US)SyntheticMR Receives Regulatory Approval for SyMRI 15 in SwitzerlandLSE:0G79Syntheticmr Ab (publ)
09/04/20243:17AMPR Newswire (US)SyntheticMR Announces the Appointment of Francois Hebert as New President, North AmericaLSE:0G79Syntheticmr Ab (publ)
06/26/20246:40AMPR Newswire (US)SyMRI 15 by SyntheticMR obtains CE-MarkingLSE:0G79Syntheticmr Ab (publ)
04/17/20244:00AMPR Newswire (US)SyntheticMR and SimonMed Expand Trials of Synthetic MRI Testing and Announce Upcoming Expansion of Synthetic Availability from SyntheticMR's SyMRI NEURO Software at SimonMed FacilitiesLSE:0G79Syntheticmr Ab (publ)
03/27/20245:37AMPR Newswire (US)SyntheticMR receives FDA 510(k) clearance for their next Generation Solution SyMRI 3DLSE:0G79Syntheticmr Ab (publ)
03/01/20242:37AMUK RegulatoryPhilips teams with SyntheticMR to deliver breakthrough AI-based quantitative brain imaging in MR to advance neurology care for patientsLSE:0G79Syntheticmr Ab (publ)
12/18/20233:19AMPR Newswire (US)SyMRI 3D by SyntheticMR Set for Early 2024 Commercial Launch Post Obtaining CE-MarkingLSE:0G79Syntheticmr Ab (publ)
11/30/20233:30AMPR Newswire (US)SyntheticMR and Philips Announce Expanded Global Partnership for SyMRI 3DLSE:0G79Syntheticmr Ab (publ)
11/30/20233:20AMPR Newswire (US)SyntheticMR and Philips Announce Expanded Global Partnership for SyMRI 3DLSE:0G79Syntheticmr Ab (publ)
02/08/20223:00AMPR Newswire (US)SyntheticMR Partners with Hyland to Utilize PACSgear Modlink SoftwareLSE:0G79Syntheticmr Ab (publ)
01/27/20226:43AMPR Newswire (US)SyMRI software is chosen for HEALthy Brain and Child Development (HBCD) studyLSE:0G79Syntheticmr Ab (publ)
08/17/20219:16AMPR Newswire (US)SyntheticMR and Siemens Healthineers collaboration extended - SyMRI NEURO now directly available through Siemens HealthineersLSE:0G79Syntheticmr Ab (publ)
06/09/20217:40AMPR Newswire (US)SyntheticMR enters joint development project with Juntendo University Hospital and Canon Medical SystemsLSE:0G79Syntheticmr Ab (publ)
06/09/20217:27AMPR Newswire (US)SyntheticMR enters joint development project with Juntendo University Hospital and Canon Medical SystemsLSE:0G79Syntheticmr Ab (publ)
03/24/20214:00AMPR Newswire (US)SyntheticMR AB receives first order from United ImagingLSE:0G79Syntheticmr Ab (publ)
02/09/20211:51AMPR Newswire (US)SyntheticMR AB partners with United ImagingLSE:0G79Syntheticmr Ab (publ)
11/12/20209:35AMPR Newswire (US)Nomination Committee appointed for the 2021 Annual General Meeting in SyntheticMRLSE:0G79Syntheticmr Ab (publ)
11/09/20204:22AMPR Newswire (US)Dr. Alex Rovira from Hospital Vall d'Hebron joins SyntheticMR's Medical Advisory BoardLSE:0G79Syntheticmr Ab (publ)
10/19/20207:45AMPR Newswire (US)Dr. Jan Fritz of NYU Langone Health joins SyntheticMR's Medical Advisory BoardLSE:0G79Syntheticmr Ab (publ)
10/01/20201:28AMPR Newswire (US)SyntheticMR signs additional collaboration agreement with GE Healthcare MRLSE:0G79Syntheticmr Ab (publ)
10/01/20201:26AMPR Newswire (US)SyntheticMR signs additional collaboration agreement with GE Healthcare MRLSE:0G79Syntheticmr Ab (publ)
09/03/20204:30AMPR Newswire (US)SyntheticMR's software solution SyMRI receives regulatory approval in JapanLSE:0G79Syntheticmr Ab (publ)
09/03/20203:58AMPR Newswire (US)SyntheticMR's software solution SyMRI receives regulatory approval in JapanLSE:0G79Syntheticmr Ab (publ)
08/11/20207:07AMPR Newswire (US)SyntheticMR's product SyMRI now compatible with additional scanners from Siemens Healthineers on the US marketLSE:0G79Syntheticmr Ab (publ)
05/18/20202:06AMPR Newswire (US)Philips Healthcare US to Include SyntheticMR's Solution in Product CatalogueLSE:0G79Syntheticmr Ab (publ)
03/27/20203:08AMPR Newswire (US)World-leading Hospital Mayo Clinic Orders SyntheticMR's Solution For Clinical RoutineLSE:0G79Syntheticmr Ab (publ)
01/08/20208:04AMPR Newswire (US)SyntheticMRs Software SyMRI now in Clinical Routine for Pediatric Whole-brain Myelin Volume QuantificationLSE:0G79Syntheticmr Ab (publ)
08/08/20196:42AMPR Newswire (US)The SyMRI® NEURO Software From SyntheticMR AB is Now Available on syngo.via Open Apps from Siemens Healthineers in the USALSE:0G79Syntheticmr Ab (publ)
11/27/20181:49AMPR Newswire (US)SyMRI Software and Philips Ingenia Elition 3.0T MR are now Jointly Marketed in the USALSE:0G79Syntheticmr Ab (publ)
 Showing the most relevant articles for your search:LSE:0G79

Your Recent History

BIT
P1H4W0
BNP Paribas Issuance
BIT
TEMP
JPM Climate Change Solut...
USOTC
UAMM
UA Multimedia (PK)
AQSE
EO.P
ESO EPIC Private Equity
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads